Boundless Bio (BOLD) Amortizatization of Intangibles (2023 - 2026)
Boundless Bio (BOLD) posted quarterly Amortizatization of Intangibles of $333000.0 for Q1 2026, down 59.19% year-over-year from $816000.0 in Q1 2025, and down 34.06% quarter-over-quarter from $505000.0 in Q4 2025.
Boundless Bio (BOLD) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Amortizatization of Intangibles for 4 consecutive years, with $333000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 59.19% year-over-year to $333000.0; the TTM figure through Mar 2026 stood at $2.1 million (down 56.99% YoY), while the FY2025 annual figure was $2.6 million, down 48.76% from the prior year.
- Amortizatization of Intangibles eased to $333000.0 in Q1 2026 per BOLD's latest filing, from $505000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.7 million in Q2 2024 and bottomed at $117000.0 in Q1 2023.
- Historically, Amortizatization of Intangibles has averaged $867538.5 across 4 years, with a median of $816000.0 in 2025.
- Annual changes were most pronounced in 2024 — Amortizatization of Intangibles surged 730.77% — and 2025, when it tumbled 59.39%.
- Boundless Bio's Amortizatization of Intangibles stood at $1.2 million in 2023, then decreased by 12.84% to $1.1 million in 2024, then plunged by 52.0% to $505000.0 in 2025, then plunged by 34.06% to $333000.0 in 2026.
- Business Quant data shows BOLD's Amortizatization of Intangibles at $333000.0 in Q1 2026, $505000.0 in Q4 2025, and $577000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Boundless Bio | 67.35 Mn | 67.35 Mn | - | 167,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 167,000.00 |
| Jun 30, 2026 | 167,000.00 |
| Mar 31, 2026 | 333,000.00 |
| Mar 31, 2026 | 333,000.00 |
| Dec 31, 2025 | 505,000.00 |
| Dec 31, 2025 | 505,000.00 |
| Sep 30, 2025 | 577,000.00 |
| Sep 30, 2025 | 577,000.00 |
| Jun 30, 2025 | 692,000.00 |
| Jun 30, 2025 | 692,000.00 |
| Mar 31, 2025 | 816,000.00 |
| Mar 31, 2025 | 816,000.00 |
| Dec 31, 2024 | 1.05 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 972,000.00 |
| Mar 31, 2024 | 972,000.00 |